Quarter 2026/Q2
| Line item | 2026 Q2 | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 |
|---|---|---|---|---|---|
| -Other Intangible Assets | $432.00M | $442.00M | $453.00M | $463.00M | $474.00M |
| Total Equity | $1.51B | $1.51B | $1.54B | $1.58B | $1.59B |
| Stockholders' Equity | $1.51B | $1.51B | $1.54B | $1.58B | $1.59B |
| Capital Stock | $2.00M | $2.00M | $2.00M | $2.00M | $2.00M |
| -Common Stock | $2.00M | $2.00M | $2.00M | $2.00M | $2.00M |
| -Preferred Stock | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Retained Earnings | -$429.00M | -$420.00M | -$384.00M | -$338.00M | -$324.00M |
| Gains/Losses Not Affecting Retained Earnings | -$7.00M | -$7.00M | -$6.00M | -$6.00M | -$5.00M |
| -Current Debt | $36.00M | $17.00M | $17.00M | $16.00M | $16.00M |
| Total Assets | $3.46B | $3.27B | $3.28B | $3.20B | $3.20B |
| Total Current Assets | $1.56B | $1.34B | $1.32B | $1.20B | $1.18B |
| Cash and Cash Equivalents & Short-Term Investments | $15.00M | $21.00M | $17.00M | $25.00M | $18.00M |
| -Cash and Cash Equivalents | $15.00M | $21.00M | $17.00M | $25.00M | $18.00M |
| Other Non-Current Liabilities | $65.00M | $63.00M | $69.00M | $71.00M | $70.00M |
| Non-Current Deferred Liabilities | $35.00M | $36.00M | $51.00M | $54.00M | $75.00M |
| -Long Term Capital Lease Obligation | $167.00M | $182.00M | $191.00M | $202.00M | $201.00M |
| Other Non-Current Assets | $29.00M | $27.00M | $24.00M | $23.00M | $31.00M |
| Total Liabilities | $1.95B | $1.76B | $1.74B | $1.62B | $1.61B |
| Total Current Liabilities | $1.23B | $1.05B | $1.04B | $907.00M | $880.00M |
| Payables | $713.00M | $584.00M | $539.00M | $481.00M | $461.00M |
| -Accounts Payable | $713.00M | $584.00M | $539.00M | $481.00M | $461.00M |
| Current Accrued Expenses | $404.00M | $367.00M | $397.00M | $321.00M | $315.00M |
| Short-Term Debt and Capital Lease Obligation | $102.00M | $87.00M | $92.00M | $93.00M | $91.00M |
| -Current Capital Lease Obligation | $66.00M | $70.00M | $75.00M | $77.00M | $75.00M |
| Other Current Liabilities | $8.00M | $10.00M | $10.00M | $12.00M | $13.00M |
| Total Non-Current Liabilities | $726.00M | $711.00M | $698.00M | $714.00M | $733.00M |
| Long Term Debt and Capital Lease Obligation | $626.00M | $612.00M | $578.00M | $589.00M | $588.00M |
| -Long Term Debt | $459.00M | $430.00M | $387.00M | $387.00M | $387.00M |
| Receivables | $1.44B | $1.22B | $1.23B | $1.10B | $1.07B |
| -Accounts Receivable | $1.44B | $1.22B | $1.23B | $1.10B | $1.07B |
| Other Current Assets | $97.00M | $98.00M | $74.00M | $72.00M | $101.00M |
| Net PPE | $331.00M | $353.00M | $372.00M | $391.00M | $387.00M |
| -Goodwill | $1.11B | $1.11B | $1.11B | $1.12B | $1.13B |
| -Accumulated Depreciation | -$412.00M | -$396.00M | -$381.00M | -$365.00M | -$351.00M |
| Additional Paid-In Capital | $1.94B | $1.93B | $1.93B | $1.92B | $1.92B |
| Goodwill and Other Intangible Assets | $1.54B | $1.55B | $1.56B | $1.59B | $1.60B |
| Total Non-Current Assets | $1.90B | $1.93B | $1.96B | $2.00B | $2.02B |
| -Gross PPE | $743.00M | $749.00M | $753.00M | $756.00M | $738.00M |
| Line item | 2025 ANNUAL | 2024 ANNUAL | 2023 ANNUAL | 2022 ANNUAL | 2021 ANNUAL |
|---|---|---|---|---|---|
| Beginning Cash Balance | $35.00M | $5.00M | $98.00M | $29.00M | $70.00M |
| -Change in Payables and Accrued Expense | -$14.00M | $52.00M | -$146.00M | $8.00M | $156.00M |
| -Change in Other Current Assets | $19.00M | $8.00M | -$14.00M | $14.00M | -$4.00M |
| Net cash flow from investing | -$71.00M | -$1.06B | -$66.00M | -$56.00M | -$38.00M |
| Net Cash Flow from Continuing Investing Activities | -$71.00M | -$1.06B | -$66.00M | -$56.00M | -$38.00M |
| Net PPE Purchase and Sale | -$57.00M | -$45.00M | -$64.00M | -$56.00M | -$38.00M |
| Net Business Purchase and Sale | -$10.00M | -$1.02B | $0.00 | $0.00 | – |
| Net Other Investing Changes | -$4.00M | – | -$2.00M | – | – |
| Ending Cash Balance | $18.00M | $35.00M | $5.00M | $98.00M | $29.00M |
| Financing Cash Flow | $1.00M | $1.11B | -$117.00M | -$183.00M | -$158.00M |
| Net Cash Flow from Continuing Financing Activities | $1.00M | $1.11B | -$117.00M | -$183.00M | -$158.00M |
| Net Issuance Payments Of Debt | $31.00M | $9.00M | -$99.00M | $451.00M | $0.00 |
| Net Common Stock Issuance | $0.00 | $1.13B | -$2.00M | $0.00 | $0.00 |
| Net Other Financing Charges | -$30.00M | -$26.00M | -$16.00M | -$634.00M | -$158.00M |
| Net Change in Cash | -$19.00M | $32.00M | -$94.00M | $71.00M | -$41.00M |
| -Change in Receivables | -$5.00M | -$109.00M | $158.00M | $92.00M | -$242.00M |
| Change in Working Capital | $0.00 | -$49.00M | -$2.00M | $114.00M | -$90.00M |
| Other Non-Cash Items | $11.00M | $223.00M | $9.00M | $6.00M | $3.00M |
| Effect of Exchange Rate Changes | $2.00M | -$2.00M | $1.00M | -$2.00M | $0.00 |
| Free Cash Flow | -$8.00M | -$57.00M | $25.00M | $253.00M | $116.00M |
| Deferred Tax | -$21.00M | -$19.00M | -$8.00M | -$20.00M | $3.00M |
| Operating Cash Flow | $51.00M | -$12.00M | $89.00M | $310.00M | $155.00M |
| Net cash flow from continuing operations | $51.00M | -$12.00M | $89.00M | $310.00M | $155.00M |
| Net Income from Continuing Operations | -$100.00M | -$290.00M | $4.00M | $92.00M | $150.00M |
| Depreciation & Depletion & Amortization | $116.00M | $87.00M | $67.00M | $86.00M | $81.00M |
No comments yet — be the first to weigh in on RXO.